COMP <GO>
EMN vs NEU // EV/EBITDA & P/E VALUATION
Eastman Chemical Company (NYSE) VS. NewMarket Corp (NYSE) • 15-METRIC TALLY: EMN 6
— NEU 7
▲ EV/EBITDA & P/E VALUATION LEADER: EMN
LAST: $66.53 (-2.06%) • MKT CAP: $7.77B
valuation
10.9x
LAST: $783.66 (-2.42%) • MKT CAP: $7.39B
valuation
13.4x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (EMN VS. NEU)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | EMN | NEU | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 21.10% | 31.50% | -10.40 | NEU | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 4.80% | 16.60% | -11.80 | NEU | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 10.9x | 13.4x | -2.50 | EMN | /valuation <GO> |
| Free Cash Flow Yield | 5.46% | 6.65% | -1.19 | NEU | /fcf-yield <GO> |
| Operating Margin | 6.60% | 20.00% | -13.40 | NEU | /operating-margins <GO> |
| Net Profit Margin | 5.40% | 15.40% | -10.00 | NEU | /net-margins <GO> |
| Revenue Growth (YoY) | -6.70% | -2.20% | -4.50 | NEU | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 4.90% | 1.43% | +3.47 | EMN | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.28 | 4.77 | -2.49 | NEU | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 6/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 60.3 | 28.4 | +31.90 | EMN | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.06 | 0.96 | +0.10 | EMN | /macro-sensitivity <GO> |
| Forward P/E Multiple | 15.3x | 16.4x | -1.10 | EMN | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $7.77B | $7.39B | $384.3M | EMN | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | EMN REV | NEU REV | EMN GROSS % | NEU GROSS % | EMN FCF | NEU FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $8.75B | $2.73B | 21.1% | 31.5% | $424.0M | $491.3M |
| FY 2024 | $9.38B | $2.79B | 24.4% | 31.8% | $688.0M | $462.3M |
| FY 2023 | $9.21B | $2.70B | — | — | $959.5M | $455.4M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
EMN // BETA 1.06
NEU // BETA 0.96